Pulse Biosciences
PLSE
56 hedge funds and large institutions have $71.8M invested in Pulse Biosciences in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 18 increasing their positions, 18 reducing their positions, and 1 closing their positions.
800% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 1
200% more call options, than puts
Call options by funds: $874K | Put options by funds: $291K
114% more capital invested
Capital invested by funds: $33.5M → $71.8M (+$38.3M)
17% more funds holding
Funds holding: 48 → 56 (+8)
0.56% more ownership
Funds ownership: 11.47% → 12.03% (+0.56%)
0% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$1.03M |
| 2 |
JP Morgan Chase
New York
|
+$425K |
| 3 |
GAM
Griffin Asset Management
New York
|
+$294K |
| 4 |
Morgan Stanley
New York
|
+$258K |
| 5 |
D.E. Shaw & Co
New York
|
+$197K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
-$215K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$161K |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$116K |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
-$89.4K |
| 5 |
BlackRock
New York
|
-$70.6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PA
51
Parallel Advisors
San Francisco,
California
| $6K | – | – | – |
|
|
CP
52
Corbenic Partners
Bethlehem,
Pennsylvania
| $2K | -$1.03K | -65 | -50% |
|
|
WOC
53
West Oak Capital
Westlake Village,
California
| $2K | – | – | – |
|
54
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $1K | – | – | – |
|
|
WIM
55
Westside Investment Management
Santa Monica,
California
| $750 | -$34.1K | -2,146 | -6% |
|
|
AIG
56
American International Group
New York
| $190 | -$3.63K | -228 | -3% |
|
57
Millennium Management
New York
| – | -$221 | -18,780 | Closed |
|
PLSE Hedge Fund Activity: Q4 2020 in Review
56 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q4 2020, worth a combined $71.8M — up 114% from $33.5M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new PLSE positions and 1 closed out — a net gain of 8 holders — while 18 added to existing stakes and 18 trimmed.
The largest buyer was Invesco, opening a new position worth an estimated $1.03M. The largest seller was Northern Trust, cutting an estimated $215K.
- 56 institutional investors held Pulse Biosciences (PLSE) as of Q4 2020, up from 48 in Q3 2020.
- Funds reported $71.8M of Pulse Biosciences stock for Q4 2020, up 114% quarter-over-quarter.
- 9 funds opened new Pulse Biosciences positions in Q4 2020 and 1 closed out, a net change of +8 holders.
- The largest Pulse Biosciences buyer in Q4 2020 was Invesco, an estimated $1.03M added.
- The largest Pulse Biosciences seller in Q4 2020 was Northern Trust, an estimated $215K sold.
Based on aggregated 13F filings for Q4 2020.